IFGL Refractories Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/w4vipfr6la8furbooqyw2a8i.pdf

Key Takeaways


Domestic vs Export: A Structural Shift

McIntosh: "The growth in India is 78% per annum, whereas the best you'll see normally in a very, very good year in America or Europe would be the low 2% or 3% in a very good year."

New Capacity: The Ramp-Up Bet

Shanmugam: "I'm happy to tell you that this magnesia carbon plant, what we have put up, is actually a backward integration, meaning we already have important customers on our clientele list for consumption of magnesia carbon."

Subsidiary Health: A Tale of Two Geographies


Strategic Initiatives: People, Processes, and New Markets

McIntosh: "We are pleased to announce that in early 2024, we commenced supply of our own high alumina brick products into the cement industry, which is the first entry into this important sector."

Acquisitions: Two Live Targets, One Abandoned

McIntosh: "American acquisition would be completely new products in the company. The acquisition target in India would be products which we currently have in our portfolio."

Guidance & Commitments

CommitmentSpecificsTimeline
Standalone revenue growthContinue growth of around 10%FY25 (annual)
Domestic revenue growthAround 17% growthFY25
Export revenue growthHold and grow marginally by 2%FY25
Standalone EBITDA margin15%FY25
Consolidated EBITDA margin12%FY25 (annual; no quarterly guidance)
Mag carbon brick utilization~50% capacityEnd of FY25
Mag carbon brick utilization80-85% capacityEnd of FY26
Mold flux powder utilization90% capacity2.5 to 3 years
Brownfield capex utilization50% this year, 80% next yearFY25 / FY26
Flux brownfield utilization30% this year, 70-80% next yearFY25 / FY26
All major capex completionCompletedBy June/July 2024
EIC (USA) profitabilitySame level as last year or slightly higherFY25
Hofmann (Germany) performanceWeak sales and profitability to continueNext couple of quarters
Czech customer receivablesPayments receivedBy end of 2025, balance in following year
2x growth targetAchieve 2x growthWithin next 5 years
US and India acquisitionsHopeful of movementWithin this financial year

Key Metrics

MetricQ4 FY24
Total income (consolidated)₹401 cr, up 7% YoY
Total income (standalone)₹216 cr
EBITDA (consolidated)₹42 cr
EBITDA margin (consolidated)10.5%; 12.8% before exceptional items
PAT (consolidated)₹12.5 cr
Cash and cash equivalents (consolidated)₹202 cr as of 31st March 2024
Standalone domestic revenue share77% of total revenue, up from 63% in Q4 FY23
Standalone export degrowth~12% YoY in Q4
Domestic growth projection for FY25~17%
Export growth projection for FY25~2% to 2.3%
Consolidated EBITDA margin guidance (yearly)12%
Capacity utilization (overall)63% to 65%
Sheffield sales (FY24 full year)~₹200 cr
Provision for exceptional items (FY24)₹38 cr to ₹39 cr
Debt on book₹62 cr, company is net debt-free